Clinical Trials Browser

Bile Duct Neoplasms

Sarcoma, Ewing, Osteosarcoma

Multiple Myeloma

Multiple Myeloma

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Urothelial Carcinoma of the Bladder

Oropharyngeal Neoplasms

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Vulvar Neoplasms

Carcinoma, Non-Small-Cell Lung

Endometrial Neoplasms

Cholangiocarcinoma

Biliary Tract Neoplasms

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Mesothelioma, Malignant, Mesothelioma

Biliary Tract Neoplasms

Muscle Invasive Bladder Urothelial Carcinoma

Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Non-squamous Non-small Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Genital Neoplasms, Male

Endometrial Neoplasms

Oropharyngeal Neoplasms

Mesothelioma

Gallbladder Cancer Unresectable

Urinary Bladder Neoplasms

Carcinoma, Hepatocellular, Hepatoblastoma

Squamous Cell Carcinoma of Head and Neck

Small Cell Lung Carcinoma

Adenocarcinoma, Pancreatic Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Neoplasms, Plasma Cell

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Oropharyngeal Neoplasms

Lung Neoplasms

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Nasopharyngeal Carcinoma, Malnutrition

Oropharyngeal Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Nasopharyngeal Carcinoma

Clinical Trials

Ablatio

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

TT4B

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

ORCA-2

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

LIGHT

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

GENE

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

SAFIR-ABC10

Drug Screening Using IMD in Bladder Cancer

ARTHOUSE

ARIAN

Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy

REDUCE-30

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

RAINBO

MINT-2

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

GCND

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

PHITT

HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer

NABPLAGEMD

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients

CompARE

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma